NeuroPace Inc Balance Sheet
NPCE|5 years of annual SEC 10-K data (FY2021-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 5 fiscal years. All figures from audited SEC 10-K filings.
NeuroPace Inc had $106M in total assets and $8M in shareholders' equity as of FY2025. Total debt was $59M against $22M in cash, resulting in $37M net debt.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | $21.7M | $13.4M | $18.1M | $6.6M | $19.2M |
| Accounts Receivable | $14.7M | $12.9M | $12.3M | $7.5M | $7.1M |
| Inventory | $16.9M | $13.4M | $11.2M | $9.7M | $7.8M |
| Current Assets | $94.1M | $81.3M | $92.7M | $97.7M | $132.8M |
| PP&E (Net) | $1.1M | $1.1M | $1.0M | $1.1M | $603.0K |
| Total Assets | $105.6M | $94.6M | $107.7M | $114.1M | $133.6M |
| Current Liabilities | $17.8M | $15.2M | $16.2M | $11.0M | $9.3M |
| Total Debt | $58.9M | $59.5M | $57.0M | $52.9M | $49.8M |
| Shareholders' Equity | $8.0M | $20.7M | $34.8M | $73.5M | -$147.8M |